Deals - Page 12

Skadden and Cleary advise French giants LVMH and Accor on deal to revive Orient Express brand

US law firms step in as French groups team up on relaunch of historic brand that will operate luxury train routes, cruises and hotels

  • 1yr

Skadden, Weil shepherd Honeywell’s $1.9bn CAES acquisition

Weil counsels seller Advent as Skadden acts for longtime client Honeywell in deal for defence tech company

  • 1yr

Kirkland, Ropes & Gray steer Bain’s $5.6bn PowerSchool acquisition

Kirkland acts for longtime client PowerSchool as private equity-led deals show signs of picking up

  • 2yrs

Raft of firms called in for Waste Management’s $7.2bn Stericycle acquisition

Latham & Watkins, Hogan Lovells, Vinson & Elkins and Baker Botts steer deal to expand top US waste management company’s healthcare footprint

  • 2yrs

Kirkland, Latham lead on Champion’s $1.2bn sale to Authentic Brands

Kirkland acts for seller HanesBrands alongside Jones Day as Latham counsels Authentic

  • 2yrs

Latham, Orrick lead on SAP’s $1.5bn WalkMe acquisition

Israeli firms Meitar and Gornitzky & Co called in on deal to buy Israeli-founded SaaS company

  • 2yrs

Wachtell, Kirkland lead on ConocoPhillips’ $22.5bn Marathon Oil acquisition

Wachtell guides ConocoPhillips as Kirkland counsels Marathon in latest energy industry mega deal

  • 2yrs

Cleary, DLA Piper and Sidley lead on T-Mobile’s $4.4bn buy of US Cellular’s wireless operations

Clifford Chance, Cravath and Washington DC boutique Wilkinson Barker Knauer also act in deal that will bring T-Mobile four million new customers

  • 2yrs

Paul Hastings, Freshfields and Addleshaws lead on Coventry Building Society’s £780m Co-op Bank acquisition

Deal to create lender with £89bn balance sheet and nearly five million customers

  • 2yrs

Complex global M&A deals face increased merger clearance challenges, study finds

Some 43% of cross-border transactions over the past four years failed to close due to regulatory scrutiny

  • 2yrs

Goodwin, Covington shepherd Biogen’s $1.8bn acquisition of rare disease drugmaker

Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences

  • 2yrs

Latham, Kirkland shepherd CyberArk’s $1.5bn Venafi acquisition

Latham guides CyberArk in acquisition of cybersecurity business from Kirkland-repped Thoma Bravo

  • 2yrs

Latham, Skadden and Paul Weiss among firms advising on $6.9bn Squarespace take private


Private equity firm Permira is leading the deal, with support from General Atlantic and Accel

  • 2yrs

Greenberg, Goodwin shepherd Ono Pharma’s $2.4bn Deciphera acquisition

Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence

  • 2yrs

Kirkland, Latham shepherd Thoma Bravo’s £4.3bn Darktrace acquisition

Kirkland acts for marquee client Thoma Bravo as Latham counsels UK-listed cyber security company

  • 2yrs
Top